Skip to content

Application of Emergent Peripheral Mechanical Circulatory Support in Transcatheter Aortic Valve Replacement for 6 Patients

Application of Emergent Peripheral Mechanical Circulatory Support in Transcatheter Aortic Valve Replacement for 6 Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04464356
Enrollment
6
Registered
2020-07-09
Start date
2013-03-01
Completion date
2020-06-01
Last updated
2020-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mechanical Circulatory Support, Transcatheter Aortic Valve Replacement

Keywords

transcatheter aortic valve replacement, mechanical circulatory support, cardiopulmonary bypass, ,extracorporeal membranous oxygenator

Brief summary

Objective: To explore the experience of transcranial aortic valve replacement (TAVR) under emergency mechanical assisted circulation (MCS).Methods: A total of 6 patients who completed TAVR with the assistance of emergency MCS in the Second Affiliated Hospital of Zhejiang University School of Medicine from March 2013 to June 2019 were retrospectively analyzed.The management of perioperative mechanical assisted circulation, preoperative evaluation, intraoperative operation and postoperative situation of patients were summarized.

Interventions

DEVICEmechanical circulatory support

mechanical circulatory support: cardiopulmonary bypass, extracorporeal membrane oxygenation(ECMO), left ventricular assist device

Sponsors

Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL

Inclusion criteria

* TAVR patient, assisted by emergency peripheral MCS due to circulatory collapse during TAVR

Exclusion criteria

* patients presented mechanical complications such as massive hemorrhage, coronary artery occlusion or left ventricular rupture.

Design outcomes

Primary

MeasureTime frameDescription
30-Day mortality rate30 days after TAVR procedure30-Day mortality rate

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026